Stifel Maintains Buy on Definitive Healthcare, Lowers Price Target to $7.5
Portfolio Pulse from Benzinga Newsdesk
Stifel analyst David Grossman maintains a Buy rating on Definitive Healthcare (NASDAQ:DH) but lowers the price target from $9.5 to $7.5.
July 31, 2024 | 3:32 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Stifel analyst David Grossman maintains a Buy rating on Definitive Healthcare but lowers the price target from $9.5 to $7.5.
The Buy rating suggests confidence in the company's long-term prospects, but the lowered price target indicates some short-term challenges or adjustments in valuation. This mixed signal is likely to result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100